Overblog Alle Blogs
Edit post Folge diesem Blog Administration + Create my blog
MENU

Mein Blog umfasst die aktuellesten News, Forschungsleistung, neuesten Produkte und Service von Sino Biological Inc. und die aktuelle News von Life Sciences. Sie können sich hier wissenschaftlich informieren.Willkommen zu meinem Blog.Viel Spaß!

Werbung

TNFRSF19 / TROY Protein

Sino Biological Inc. liefert TNFRSF19 / TROY Protein mit höherer Qualität und günstiger Kosten im Vergleich mit anderen globalen Lieferanten.

Weitere Informationen über TNFRSF19 / TROY Protein lesen Sie bitte: http://www.sinobiological.com/TNFRSF19-TROY-Protein-g-10186.html

Produkt-Information von TNFRSF19 / TROY Protein

Synonym TNFRSF19, TAJ, TROY
Protein Construction

A DNA sequence encoding the human TNFRSF19 (Q9NS68-2) (Met1-Leu170) was expressed, fused with the Fc region of human IgG1 at the C-terminus.

Source Human
Expression Host Human Cells

QC Testing von TNFRSF19 / TROY Protein

Purity > 85 % as determined by SDS-PAGE SDS-PAGE:
SDS-PAGE

TNFRSF19 protein

Endotoxin < 1.0 EU per μg of the protein as determined by the LAL method
Stability Samples are stable for up to twelve months from date of receipt at -70℃
Predicted N terminal Glu 30
Molecular Mass

The recombinant human TNFRSF19/Fc is a disulfide-linked homodimer. The reduced monomer comprises 382 amino acids and has a predicted molecular mass of 42.5 kDa. The apparent molecular mass of the protein is approximately 52-57 kDa in SDS-PAGE under reducing conditions.

Formulation Lyophilized from sterile PBS, pH7.4.
  1. Normally 5 % - 8 % trehalose and mannitol are added as protectants before lyophilization. Specific concentrations are included in the hardcopy of COA.

Usage Guide von TNFRSF19 / TROY Protein

Storage Store it under sterile conditions at -70℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution A hardcopy of COA with reconstitution instruction is sent along with the products. Please refer to it for detailed information.

Verwandte Produkte & Themen von TNFRSF19 / TROY Protein

Related Areas:

Stem Cell>>Neural Stem Cell (NSC)>>Glial Cell Markers>>TNFRSF19/TROY

Immunology>>Cytokine & Receptor>>TNF Superfamily>>TNFRSF19/TROY

Proteins:
Molecule Species Description //For Detailed Info. and Price------CLICK! Cat. No
TNFRSF19/TROY Human TNFRSF19 / TROY Protein, Recombinant 13387-H02H
TNFRSF19/TROY Mouse TNFRSF19/TROY Protein, Recombinant 50148-M03H
TNFRSF19/TROY Mouse TNFRSF19/TROY Protein, Recombinant 50148-M08H
Antibodies:
Molecule Application Description //For Detailed Info. and Price------CLICK! Cat. No
Mouse
TNFRSF19/TROY
WB, ELISA TNFRSF19/TROY Antibody, Rabbit PAb 50148-RP01
Mouse
TNFRSF19/TROY
WB, ELISA TNFRSF19/TROY Antibody, Rabbit PAb (Antigen Affinity Purified) 50148-RP02
Mouse
TNFRSF19/TROY
WB, ELISA TNFRSF19 / TROY Antibody 50148-R208

Beschreibung von TNFRSF19 / TROY Protein

Tumor necrosis factor receptor superfamily member 19, also known as, Toxicity and JNK inducer, TNFRSF19, TRADE and Troy, is a member of the TNF-receptor superfamily and contains 3 TNFR-Cys repeats. TNFRSF19 is highly expressed in adult brain, and in embryos from day 11-17, but not earlier. It is detected in embryonic brain and epithelium, and at lower levels in adult heart, lung and liver. In neonatal mice, TNFRSF19 is mainly expressed in hair follicles and neuron-like cells in the cerebellum, but not in the skin epidermis. TNFRSF19 has been shown to interact with TRAF family members, and to activate JNK signaling pathway when overexpressed in cells. This receptor is capable of inducing apoptosis by a caspase-independent mechanism, and it is thought to play an essential role in embryonic development. TNFRSF19 is the first TNFRSF member that is identified as a biomarker for melanoma. TNFRSF19 also presents a potentially novel cell surface signaling target for inhibitors, cell and/or antibody-based immunotherapies.

References

  1. Hu S. et al., 1999, Genomics. 62: 103-7.
  2. Eby MT. et al., 2000, J Biol Chem. 275: 15336-42.
  3. Kojima T. et al., 2000, J Biol Chem. 275: 20742-7.
  4. Spanjaard RA. et al., 2007, Int J Cancer. 120 (6): 1304-10.
Werbung
Zurück zu Home
Diesen Post teilen
Repost0
Um über die neuesten Artikel informiert zu werden, abonnieren:
Kommentiere diesen Post